Stay updated on Iberdomide Combo with Elotuzumab in Myeloma Clinical Trial
Sign up to get notified when there's something new on the Iberdomide Combo with Elotuzumab in Myeloma Clinical Trial page.

Latest updates to the Iberdomide Combo with Elotuzumab in Myeloma Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedA new revision entry v3.6.3 was added to the study history, superseding the previous v3.6.2 and signaling an updated version of the study record.SummaryDifference0.1%

- Check21 days agoChange DetectedA new revision entry v3.6.2 was added to the record history, and the previous entry v3.6.0 was removed, indicating an update to the page's revision history.SummaryDifference0.1%

- Check35 days agoChange DetectedThe history now shows recruitment has ended with 'No longer looking for participants', signalling cessation of enrollment. A new revision entry 'Revision: v3.6.0' was added, replacing the previous 'Revision: v3.5.5' in the version history.SummaryDifference0.4%

- Check42 days agoChange DetectedA new history revision (v3.5.5) has been added to the study record’s Version History, replacing the previous revision (v3.5.4).SummaryDifference0.1%

- Check63 days agoChange DetectedA new revision entry v3.5.4 was added to the Record History, and the previous revision label v3.5.3 was removed from the visible changes.SummaryDifference0.1%

- Check85 days agoChange DetectedThe page’s footer revision indicator was updated from v3.5.2 to v3.5.3, reflecting a system/site version change rather than a change to the clinical trial record itself.SummaryDifference0.1%

Stay in the know with updates to Iberdomide Combo with Elotuzumab in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Iberdomide Combo with Elotuzumab in Myeloma Clinical Trial page.